Solid Tumors, Adult
23 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors (NCT05430373) | Grit Biotechnology | 2022-05-23 |
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors (NCT05354323) | NEC OncoImmunity AS | 2022-05-05 |
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
| Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors (NCT05018273) | Nykode Therapeutics ASA | 2021-12-21 |
| Study of ON 123300 in Patients With Advanced Cancer (NCT04739293) | Traws Pharma, Inc. | 2021-05-13 |
| Imaging of Solid Tumors Using FAP-2286 (NCT04621435) | Thomas Hope | 2020-12-14 |
| A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors (NCT04587479) | Jacobio Pharmaceuticals Co., Ltd. | 2020-11-23 |
Track Solid Tumors, Adult automatically
Every clearance here is in the API, with alerts when new ones post.